Sandbox: maria gallery: Difference between revisions
Jump to navigation
Jump to search
Replaced content with "==Risk Factors==" |
No edit summary |
||
Line 1: | Line 1: | ||
==Risk Factors== | ==Risk Factors== | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 250px; color: #FFFFFF;"|'''Prognostic Factor''' | |||
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Age'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:* Older age at the time of diagnosis is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Gender'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:* Males are associated with a worse prognosis when compared to females. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Performance status'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:* Patient's poor [[performance status]] is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Stage'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*Binet stages B and C or Rai stages 2-4 are associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Lymphocyte doubling time'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*A rapid [[lymphocyte]] doubling time is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Genetic mutations'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Deletion of [[chromosome 17]] short arm and [[chromosome 11]] long arm are associated with a worse prognosis. | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Prolymphocytes percent'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*An increased percentage of [[prolymphocyte]]s is associated with a worse prongnosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Histological analysis'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Diffuse [[histology]] on [[bone marrow aspiration]] is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Lactate dehydrogenase (LDH) level'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Elevated level of [[LDH]] is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''β2-microglobulin level '''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Elevated level of β2-microglobulin level is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Lymphocyte surface markers'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Over expression of [[CD38]] is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Immunoglobulin (Ig)VH gene'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*The absence of IgVH [[gene]] mutation is associated with a worse prognosis. | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Membrane-bound proteins'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*The expression of zeta-chain-associated protein kinase 70 (ZAP) is associated with a worse prognosis. | |||
|} |
Revision as of 19:41, 10 November 2015
Risk Factors
Prognostic Factor | Description |
---|---|
Age |
|
Gender |
|
Performance status |
|
Stage |
|
Lymphocyte doubling time |
|
Genetic mutations |
|
Prolymphocytes percent |
|
Histological analysis |
|
Lactate dehydrogenase (LDH) level |
|
β2-microglobulin level |
|
Lymphocyte surface markers |
|
Immunoglobulin (Ig)VH gene |
|
Membrane-bound proteins |
|